Autolus Therapeutics (AUTL)

• Market cap: $482M
• 1 day: -5.24%
• 5 days: -3.72%
• 1 month: 21.48%
• 3 months: 2.84%
• 6 months: -26.72%
• Year to date: -3.21%
• 1 year: -23.31%
• 5 years: -79.34%
• 10 years: -92.76%
• Sector: Healthcare
• Industry: Biotechnology

About: Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.

Employees: 647